Aidspan - Mauritania

Global Fund Grants to Mauritania as of 31 August 2010

The information provided here is based on data available from the Global Fund website. Based on that data, we provide a comparative evaluation of how each grant performed during its first 2 years (Phase 1). Performance information for later years is also provided but has not been evaluated. Aidspan is currently developing a more comprehensive evaluation methodology which will provide comparative analyses of grant performance during every phase: Phase 1 (Years 1-2), Phase 2 (Years 3-5) and Rolling Continuation Channel (RCC) covering subsequent years.

All money amounts are in US dollars. Grants are rated by Aidspan according to the following color-coded scheme:

A: On or ahead of schedule

B: Up to 3 months behind

C: 3 to 6 months behind

D: Over 6 months behind

N: Not rated

Global Fund grants to Mauritania

6 grants, worth a total of $48,265,246, as follows:

	Phase 1 - Years 1-2	Year 3 Onwards	Total
HIV/AIDS	$9,345,792 (approved)	$9,707,986 (projected)	$19,053,778 (projected)
TB	$5,546,428 (agreed)	$6,533,906 (projected)	$12,080,334 (projected)
Malaria	$5,139,170 (agreed)	$11,991,964 (projected)	$17,131,134 (projected)
Total	$20,031,390 (approved)	$28,233,856 (projected)	$48,265,246 (projected)
Disbursed	$12,301,204 (61%)	$2,528,601 (9%)	$14,829,805 (31%)

Performance of Mauritania grants

A: Grants on or ahead of schedule

D:	On average, the rated Mauritania grants are 14.7 months behind schedule

B: Grants up to 3 months behind schedule

C: Grants 3 to 6 months behind schedule

D: Grants over 6 months behind schedule

N: Grants not rated by Aidspan

Total number of grants:

Global Fund links for Mauritania

Data regarding HIV/AIDS, TB and malaria in Mauritania

Country-specific Data Sheet on HIV, TB and malaria from www.GlobalHealthFacts.org (a service of Kaiser Family Foundation, using data from UN and other sources)
Country-specific Epidemiological Fact Sheet on HIV from WHO

In the table below, click on any grant to see that grant's background details and progress to date

Round /
NSA Wave

Disease Component

Applicant

Title

Grant Number
(Click for details)

Principal Recipient

Current Status

Phase 1 - Years 1-2

Phase 2 - Years 3-5

Phase 1 + Phase 2

Disbursed so far

Phase 1 rating:
Months ahead of or behind schedule

Round 2

Malaria

CCM

Consolidation and extension of malaria prevention interventions in Mauritania

MRT-202-G02-M

The United Nations Development Programme

Phase 1 approved. Agreement signed. Fully disbursed.

Phase 2 approved. Agreement signed. 59% disbursed.

P1 (agreed) :	$824,044
P2 (agreed) :	$2,074,949
P1+P2 (agreed) :	$2,898,993
Disbursed:	$2,051,161

D: 6.1 months behind

Round 2

CCM

Consolidation and Extension of Tuberculosis Prevention in Mauritania

MRT-202-G01-T

The United Nations Development Programme

Phase 1 approved. Agreement signed. Fully disbursed.

Phase 2 approved. Agreement signed. 80% disbursed.

P1 (agreed) :	$1,104,742
P2 (agreed) :	$1,623,147
P1+P2 (agreed) :	$2,727,889
Disbursed:	$2,406,225

C: 3.7 months behind

Round 5

HIV/AIDS

CCM

Programme de renforcement de la reponse nationale de lutte contre le VIH/SIda en Mauriatnie

MRT-506-G03-H

Sécretariat Exécutif, Comité National de Lutte Contre le SIDA

Phase 1 approved. Agreement signed. 74% disbursed.

Phase 2 approved. Agreement signed. No disbursements yet.

P1 (agreed) :	$6,573,416
P2 (agreed) :	$8,537,857
P1+P2 (agreed) :	$15,111,273
Disbursed:	$4,887,857

D: 29.9 months behind

Round 6

Malaria

CCM

Appui au reforcement de la lutte contre le paludisme en Mauritanie

MRT-607-G04-M

The United Nations Development Programme

Phase 1 approved. Agreement signed. 57% disbursed.

Phase 2 not yet approved. No disbursements yet.

P1 (agreed) :	$4,315,126
P2 (projected) :	$9,917,015
P1+P2 (projected) :	$14,232,141
Disbursed:	$2,460,203

D: 18.0 months behind

Round 6

CCM

Extention et reforcement de la strategie DOTS au niveau de 100% des Centres de Santé/Hopitaux Regionaux et de 60% des Postes de Santé

MRT-607-G05-T

The United Nations Development Programme

Phase 1 approved. Agreement signed. 68% disbursed.

Phase 2 not yet approved. No disbursements yet.

P1 (agreed) :	$4,441,686
P2 (projected) :	$4,910,759
P1+P2 (projected) :	$9,352,445
Disbursed:	$3,024,357

D: 16.0 months behind

Round 8

HIV/AIDS

CCM

Not yet known

Round 8 HIV/AIDS

Not yet known

Phase 1 approved. Agreement not yet signed. No disbursements yet.

Phase 2 not yet approved. No disbursements yet.

P1 (approved) :	$2,772,376
P2 (projected) :	$1,170,129
P1+P2 (projected) :	$3,942,505
Disbursed:	$0

N: not yet rated

Round 1 grants were approved by the Fund's board on 24 April 2002, Round 2 grants were approved on 31 January 2003, Round 3 grants were approved on 17 October 2003, Round 4 grants were approved on 30 June 2004, Round 5 grants were approved on 30 September 2005, Round 6 grants were approved on 3 November 2006, Round 7 grants were approved on 13 November 2007, Round 8 grants were approved on 8 November 2008, Round 9 grants were approved on 11 November 2009, and Wave 1 NSA grants were approved on 11 November 2009

The Global Fund bears no responsibility for this analysis. The computation of months ahead of or behind schedule was conducted by Aidspan using disbursement data obtained from the Global Fund's website.

Aidspan (www.aidspan.org, info@aidspan.org) is publisher of Global Fund Observer.